Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

66.7%

2 terminated/withdrawn out of 3 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT00430274Completed

Photographic Imaging of the Retina and Optic Nerve Head of Glaucoma Patients and Normal Controls

Role: lead

NCT00313118Withdrawn

Mean Values of Oxidative Stress Parameters in Healthy Subjects

Role: lead

NCT00313092Terminated

Obstructive Sleep Apnea Syndrome in Glaucoma

Role: lead

All 3 trials loaded